Related Experiment Video
Updated: Jun 23, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
A Retrospective Cohort Study of Extended Dupilumab Dosing in Atopic Dermatitis: Assessing the Impact on Disease
Jessica McClatchy1, Vanessa Tran1, Gayle Ross1,2
1Dermatology Department, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Abstract:
Dupilumab is effective for moderate-to-severe atopic dermatitis, but optimal long-term dosing is unclear. In this single-centre retrospective study, 49 patients underwent dose extension to 300 mg Q3W or 300 mg Q4W, with EASI scores remaining low and stable over 18 months. Patients extending for good disease control had higher EASI90 rates. The impact of age, disease severity and therapy duration remains uncertain.
Related Concept Videos
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dosage Regimens: Designs and Approaches
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Dosage Regimens: Partial Pharmacokinetic Parameters
Bioavailability Study Design: Single Versus Multiple Dose Studies
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...